Biosign Flu A+B Rapid Test Kit, 25 test kit by Germaine Labs BSP-510-25

An In vitro rapid qualitative test that detects influenza type A and type B antigens directly from nasal swab, nasopharyngeal swab and nasal aspirate/wash specimens. Features: Differentiates between Influenza Type A and B, on a single test device Produces results in 10 to 15 minutes Each test device includes built-in controls Each kit comes with external controls Meets FDA performance criteria for influenza tests stated in code 21 CFR 866.3328 CLIA Complexity: Moderate complexity when used with nasal wash/aspirate samples CLIA Waived when used with nasal and nasopharyngeal swabs Intended for physician office use Expected expiration - 12-18 month expiration dating window 18 kits per case